NJ State Employees Deferred Compensation Plan’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
2019
Q1
$40K Hold
2018
Q4
$28K Hold
2018
Q3
$81K Hold
2018
Q2
$88K Hold
2018
Q1
$121K Hold
2017
Q4
$156K Hold
2017
Q3
$172K Sell
2017
Q2
$160K Hold
2017
Q1
$442K Sell
2016
Q4
$540K Hold
2016
Q3
$800K Hold
2016
Q2
$862K Hold
2016
Q1
$784K Hold
2015
Q4
$1.58M Buy